NETILDEX DIN 02493187
Status: Approved
Holder: SIFI S.P.A.
Health Canada record
| Active ingredient(s) | NETILMICIN (NETILMICIN SULFATE) 0.3 %; DEXAMETHASONE (DEXAMETHASONE SODIUM PHOSPHATE) 0.1 % |
|---|
| Dosage form | Solution |
|---|
| Route | Ophthalmic |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | S01CA01 DEXAMETHASONE AND ANTIINFECTIVES |
|---|
| Original market date | |
|---|
| Current status date | 15-Sep-2022 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Sifi S.P.A. — licence , not currently licensed, last inspection rating C (2022-03-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NETILMICIN (NETILMICIN SULFATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02493195 | NETILDEX | SIFI S.P.A. | Solution | NETILMICIN (NETILMICIN SULFATE) 0.3 %; DEXAMETHASONE (DEXAMETHASONE SODIUM PHOSPHATE) 0.1 % | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 28972 | 2022-09-15 | New Drug Submission (NDS) | Administrative: Change in Product Ownership |
| 22794 | 2019-10-18 | New Drug Submission (NDS) | |
Request a quote for NETILDEX
How to read a Canadian DIN record